688091 logo

Shanghai Yizhong Pharmaceutical Co., Ltd. Stock Price

SHSE:688091 Community·CN¥10.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

688091 Share Price Performance

CN¥0
-41.26 (-100.00%)
CN¥0
-41.26 (-100.00%)
Price CN¥0

688091 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with solid track record.

1 Risk
1 Reward

Shanghai Yizhong Pharmaceutical Co., Ltd. Key Details

CN¥317.1m

Revenue

CN¥0

Cost of Revenue

CN¥317.1m

Gross Profit

CN¥252.9m

Other Expenses

CN¥64.1m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 28, 2026
0.31
100.00%
20.23%
0%
View Full Analysis

About 688091

Founded
2009
Employees
415
CEO
Jingsong Zhou
WebsiteView website
www.yizhongpharma.com

Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the development of anti-tumor drugs and related products in China. It also offers paclitaxel polymer nanomicelles for the treatment of non-small cell lung cancer, as well as various types of cancer, including esophageal cancer, gastric cancer, nasopharyngeal carcinoma, pancreatic cancer, breast cancer, gynecological tumors, etc. The company was founded in 2009 and is headquartered in Shanghai, China.

Recent 688091 News & Updates

Recent updates

No updates